Oppenheimer Reiterates Outperform Rating for KALA BIO (NASDAQ:KALA)
KALA BIO (NASDAQ:KALA – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Oppenheimer in a research note issued to investors on Monday,Benzinga reports. They currently have a $15.00 target price on the stock. Oppenheimer’s target price suggests a potential upside of 266.75% from the stock’s current price. Separately, HC […]
KALA BIO (NASDAQ:KALA – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Oppenheimer in a research note issued to investors on Monday,Benzinga reports. They currently have a $15.00 target price on the stock. Oppenheimer’s target price suggests a potential upside of 266.75% from the stock’s current price. Separately, HC […]
